AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Yingying Zhang
Joined Jul 2022
Public Documents
1
July 26, 2022
The combination of omalizumab improves the safety and efficacy of allergen immunother...
Yingying Zhang
